JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus maintains an Overweight rating on Boston Scientific (NYSE:BSX) and raises the price target from $72 to $82.
April 25, 2024 | 4:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Robbie Marcus maintains an Overweight rating on Boston Scientific and raises the price target from $72 to $82.
The upgrade in price target by a reputable analyst from JP Morgan signifies a strong confidence in Boston Scientific's future performance. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100